The FTC is suing three pharmacy benefit managers for allegedly driving up the cost of insulin, but there is very little other ...
The owner of one of the three largest pharmacy middlemen in the United States filed suit on Sept. 16 to quash an attempt by ...
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...
The vice president has campaigned on holding big business accountable but has privately sought advice from CEOs and investors ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...
One complicating factor is manufacturer rebates, which are discounts on prescription list prices provided by drug manufacturers to pharmacy benefit managers, which in turn may share some or all of ...
essentially middlemen in the supply chain, are manipulating the drug pricing process for their own profit. The six largest PBMs control 95% of the prescription drug marketplace and they are ...
The Dean of the Faculty of Renewable Natural Resources, University of Ibadan, Professor Adejoke Akinyele, has called on the federal government to eliminate the activities of middlemen in the food ...
The U.S. Drug Enforcement Administration (DEA) has allowed an increase in Vyvanse production of around 24 percent to help with the ADHD drug shortage nationwide. The DEA greenlighted the spike in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback